Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OPDC Career Development Fellow Natalie Connor-Robson was first generation in her family to go to university and is now delighted to be sharing STEM career advice with students taking part in the In2scienceUK programme.

Dr Natalie Connor-Robson from the OPDC's Wade-Martins Group has been virtually hosting students via the In2scienceUK programme this summer.

She has developed an online teaching module as part of a 2-week STEM summer online placement for young people from underrepresented and disadvantaged backgrounds in order to give them access to invaluable STEM skills and career guidance.

Concentrating primarily on Parkinson's, the module teaches students how important it is to understand the molecular changes that happen in the brain in neurodegeneration, as doing so will ultimately help scientists to design drugs that halt the progression or cure these diseases. Students are taught to consider what happens in the brain during Parkinson's and how a patient would be diagnosed. They also look at what the genetics of Parkinson's tells us about how it effects neurons in the brain and concentrate on the role of the autophagy pathway – the cells waste clearance system. 

Dr Connor-Robson began by delivering the main lecture on neurodegeneration, which was followed by a Q&A session where students learned how she chose her course at university, her experience of research and how she ended up working at Oxford. She then developed some tasks for the students to work on based on real experimental data from the lab before providing another feedback lecture on the tasks. Dr Connor-Robson said: "We went through how I did the experiments to get the data I provided them with and they now get this week to be a biochemist and a neuropathologist and analyse the data!" 

"The idea is for the students to experience what a career in STEM can look like and to give them a more in depth look at a particular subject area. The students also receive training for example CVs and personal statement workshops. The idea is to encourage people from all backgrounds into STEM careers." 

Read more: "Natalie Connor-Robson talks team effort, diversity and neurodegenerative Diseases" (In2scienceUK website).

 

The Department has hosted students via the programme in the past, providing an opportunity not only for students to gain insight into our work but also for departmental staff to engage with the wider community. See "DPAG Researchers collaborate with In2scienceUK" for more information.

Similar stories

Oxford Parkinson’s Disease Centre host the 2022 Oxford Parkinson’s Research Day

On Tuesday 29th November 2022, Professor Richard Wade-Martins and Professor Michele Hu from the Oxford Parkinson’s Disease Centre (OPDC) hosted the Oxford Parkinson’s Research Day at the Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, South Parks Road, Oxford.

Strong performance for DPAG cardiac research at the Oxford BHF CRE Annual Symposium

Congratulations are in order for Kaitlyn Dennis, Dr Ni Li and Dr KC Park on their awards at this year's major showcase for Oxford's British Heart Foundation funded researchers.

Louisa Zolkiewski awarded the Bruce Cattanach Prize 2022

Congratulations are in order for Louisa Zolkiewski, who completed her DPhil studies this year, on being awarded the 2022 Bruce Cattanach Prize by the Genetics Society for her DPhil thesis.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.